Immunai

Screenshots

About Immunai

Immunai is a transformative force in immunotherapy, leveraging advanced technologies to map the immune system with unparalleled precision. Its proprietary platform, AMICA™, revolutionizes the development of immunomodulatory therapeutics by integrating multi-omic single-cell analysis with machine learning and functional genomics. Designed for biopharmaceutical companies and academic institutions, Immunai simplifies drug discovery and development, accelerating the identification of new therapeutic targets and enhancing our understanding of immune system mechanisms. Key features include a comprehensive immune cell atlas, advanced data engineering, machine learning capabilities, integration of functional genomics, and in vitro model systems for testing immune responses. Immunai stands out with its innovative technology and strategic partnerships, making it indispensable for researchers and organizations aiming to lead in the discovery of next-generation therapies.

Key Features

• AMICA™ Platform: A comprehensive immune cell atlas that combines multi-omic data from single cells to provide a detailed view of the immune system.
• Data Engineering: Advanced data handling capabilities that manage and analyze large volumes of multi-omic data.
• Machine Learning: Utilizes cutting-edge AI to interpret complex biological data and uncover patterns that guide therapeutic discovery.
• Functional Genomics and Experimental Immunology: Integrates experimental approaches with genomic data to validate findings and accelerate therapeutic development.
• In Vitro Model Systems: Supports the simulation and testing of immune responses, facilitating rapid advancements in immunotherapy.

Use Cases

Target Audience

Supported Languages

Platform Availability

Pricing

Technical Information

Resources and Community

growing

Tags